Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04827368 · ClinicalTrials.gov registry record
Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease
A clinical trial of Ulcerative Colitis and Crohn Disease, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 292
- Enrollment target
- 1
- Study location
NCT04827368 is a study of Ulcerative Colitis and Crohn Disease that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 292 participants, below the 2,055-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04827368, a study of Ulcerative Colitis and Crohn Disease, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 292 participants
- Enrollment target
- 1
- Study location
Study Summary
Inflammatory Bowel Disease (IBD) are chronic diseases of the gut comprising Crohn's Disease (CD) and Ulcerative Colitis (UC). The symptoms of IBD consist of diarrhea, abdominal discomfort, weight loss, fatigue and rectal bleeding. However, symptoms and treatment vary between patients. Early management of IBD can lead to better response rates and decrease the risk of irreversible bowel damage and future disease complications such as surgeries. Current clinical tools for diagnosis and or assessing progression of IBD are either invasive (colonoscopy), have low patient acceptance (fecal calprotectin) or low accuracy (C-reactive protein). The purpose of this study is to collect clinical data and samples (including blood, breath and stool) donated by patients with IBD and patients with no IBD (controls) to facilitate research that may result in the development of new non-invasive methods of diagnosing IBD and understand the progression of the disease over time in order to better manage IBD patients.
Conditions Studied
Interventions
- OTHER Breath Test
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04827368
The ClinicalTrials.gov registry entry for NCT04827368 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,055-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (86% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which Breath Test is the first listed.
NCT04827368 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04827368 about?
NCT04827368 is a clinical study titled "Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease". Inflammatory Bowel Disease (IBD) are chronic diseases of the gut comprising Crohn's Disease (CD) and Ulcerative Colitis (UC). The symptoms of IBD consist of diarrhea, abdominal discomfort, weight loss, fatigue and rectal bleeding. However, symptoms and treatment vary between patients. Early manageme...
What is the current status of trial NCT04827368?
This trial is currently active not recruiting. The enrollment target is 292 participants. The study started on 2021-03-22. Estimated completion is 2026-06-30.
What conditions does trial NCT04827368 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease, IBD.
What interventions are being tested in trial NCT04827368?
The interventions under investigation include: Breath Test (OTHER).
Who is sponsoring clinical trial NCT04827368?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04827368 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.